336
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Designing and optimization of novel human LMTK3 inhibitors against breast cancer – a computational approach

&
Pages 51-59 | Received 18 Dec 2015, Accepted 09 Feb 2016, Published online: 08 Apr 2016

References

  • Harris J, Lippman ME, Veronesi U, et al. Breast cancer (3 parts). N Engl J Med 1992;327:319–479
  • Smith H, Kammerer-Doak D, Barbo D, Sarto G. Hormone replacement therapy in the menopause: a pro opinion. CA Cancer J Clin 1996;46:343–63
  • Labrie F, Labrie C, Belanger A, et al. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol 1999;69:51–84
  • Stebbing J, Filipovic A, Giamas G. Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution. evolution. Oncotarget 2011;2:428–9
  • Stebbing J, Crane J, Gaya A. Breast cancer (metastatic). Clin Evid 2006;15:2331–59
  • Wu RC, Qin J, Yi P, et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 2004;15:937–49
  • Jiang J, Sarwar N, Peston D, et al. Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease free and overall survival in breast cancer patients. Clin Cancer Res 2007;13:5769–76
  • Giamas G, Castellano L, Feng Q, et al. CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen dependent manner and regulates ERalpha-AIB1 interactions. Nucleic Acids Res 2009;37:3110–23
  • Giamas G, Stebbing J, Vorgias CE, Knippschild U. Protein kinases as targets for cancer treatment. Pharmacogenomics 2007;8:1005–16
  • Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene 2000;19:5548–57
  • Giamas G, Filipović A, Jacob J, et al. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nat Med 2011;17:715–19
  • Johnson AB, O'Malley BW. Erasing breast cancer resistance through the kinome. Nat Med 2011;17:660–1
  • Stebbing J, Filipovic A, Ellis IO, et al. LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome. Breast Cancer Res Treat 2012;132:537–44
  • Xu Y, Zhang H, Giamas G. Targeting lemurs against cancer metastasis. Oncotarget 2014;5:5192–3
  • Castrignano T, De Meo PD, Cozzetto D, et al. The PMDB protein model database. Nucleic Acids Res 2006;34:D306–9
  • Lin A, Cai Z, Hu G, Li Q. Identification of ALK5 inhibitor via structure-based virtual screening and ADMET prediction. J Recept Signal Transduct Res 2015;35:559–64
  • Anbarasu K, Jayanthi S. Structural modeling and molecular dynamics studies on the human LMTK3 domain and the mechanism of ATP binding. Mol Biosyst 2014;10:1139–45
  • Irwin JJ, Shoichet BK, Mysinger MM, et al. Automated docking screens: a feasibility study. J Med Chem 2009;52:5712–20
  • Trott O, Olson AJ. AutoDock VINA: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. accuracy docking a scoring, optimization multithreading. J Comput Chem 2010;31:455–61
  • Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 2010;24:417–22
  • Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998;19:1639–62
  • Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011;51:2778–86
  • Small-molecule drug discovery suite 2015-3: QikProp, version 4.5, New York: Schrödinger, LLC. http://www.schrodinger.com/QikProp/
  • Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comp Phys Comm 1995;91:43–56
  • Lindahl E, Hess B, Spoel VD. GROMACS 3.0: a package for molecular simulation & trajectory analysis. J Mol Model 2001;7:306–17
  • Schuttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2004;60:1355–63
  • Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1996;18:1463–72
  • Miyamoto S, Kollman PA. Settle: An analytical version of the SHAKE & RATTLE algorithm for rigid water models. J Comput Chem 1992;13:952–62
  • Amadei A, Linssen AB, Berendsen HJ. Essential dynamics of proteins. Proteins 1993;17:412–25
  • Turner PJ. XMGRACE, Version 5.1.19. Center for Coastal & L&-Margin Research, Oregon Graduate Institute of Science & Technology, Beaverton, OR. http://www.http://plasma-gate.weizmann.ac.il/Grace/
  • Kumari R, Kumar R, Open Source Drug Discovery C, Lynn A. g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 2014;54:1951–62
  • Baker NA, Sept D, Joseph S, et al. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001;98:10037–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.